Copenhagen Hospital Corporation
12
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
16.7%
2 terminated/withdrawn out of 12 trials
71.4%
-15.1% vs industry average
33%
4 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen
Role: collaborator
The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease
Role: collaborator
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
Role: collaborator
Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis
Role: collaborator
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
Role: collaborator
Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia
Role: collaborator
Best Bypass Surgery (BBS) Trial
Role: collaborator
Copenhagen Arterial Revascularization Randomized Patency and Outcome Trial
Role: collaborator
Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response
Role: collaborator
Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis
Role: collaborator
Assertive Community Treatment in Copenhagen
Role: collaborator
Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial Fibrillation
Role: collaborator
All 12 trials loaded